Mesoblast Limited (MESO)

Mesoblast Cash Flow Statement

Financials in millions USD. Fiscal year is July - June.

Year Ending	TTM	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019
Net Income	-73.06	-81.89	-91.35	-98.81	-77.94	-89.8
Other Operating Activities	13.96	18.62	25.57	-1.94	27.52	32.01
Operating Cash Flow	-59.1	-63.27	-65.78	-100.75	-50.42	-57.79
Capital Expenditures	-0.23	-0.26	-0.16	-1.65	-2.1	-0.28
Acquisitions	-	0	0	0	-1.03	-0.72
Change in Investments	-	0.12	0	0	0	0
Other Investing Activities	0.19	-0.05	-0.08	-	-0.15	-
Investing Cash Flow	-0.05	-0.19	-0.23	-1.65	-3.27	-1
Share Issuance / Repurchase	83.28	88.64	0.21	106.27	144.95	30.26
Debt Issued / Paid	-4.59	-3.23	-11.85	-2.94	-1.63	41.96
Other Financing Activities	-10.87	-10.9	1.78	5.21	-12.22	-0.61
Financing Cash Flow	67.82	74.5	-9.87	108.53	131.1	71.61
Exchange Rate Effect	1.26	-0.17	-0.55	1.42	1.5	-0.16
Net Cash Flow	8.67	11.04	-75.88	6.14	77.41	12.82
Free Cash Flow	-59.33	-63.53	-65.94	-102.4	-52.51	-58.07
Free Cash Flow Margin	-818.02%	-846.99%	-645.76%	-1377.40%	-163.31%	-347.26%
Free Cash Flow Per Share	-0.73	-0.86	-1.01	-1.58	-0.98	-1.17

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).